✦ LIBER ✦

Targeting alpha-fetoprotein represses the proliferation of hepatoma cells via regulation of the cell cycle

✍ Scribed by Hua Tang; Xiao-Yan Tang; Min Liu; Xin Li

Book ID: 116347942
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 822 KB
Volume: 394
Category: Article
ISSN: 0009-8981
DOI: 10.1016/j.cca.2008.04.012

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Alpha-fetoprotein enhances the prolifera

Alpha-fetoprotein enhances the proliferation of human hepatoma cells in vitro

✍ Xing-Wang Wang; Hong Xie 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 558 KB

Cell cycle progression by the repression

Cell cycle progression by the repression of primary cilia formation in proliferating cells

✍ Hidemasa Goto, Akihito Inoko, Masaki Inagaki 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 614 KB

Methylation of the alpha-fetoprotein gen

Methylation of the alpha-fetoprotein gene in isogenic rat hepatoma and liver cell lines

✍ Keiko Sakuma; Jeffry R. Cook; Catharine L. Smith; Jen-Fu Chiu 📂 Article 📅 1987 🏛 Elsevier Science 🌐 English ⚖ 776 KB

PP-050 Alpha-fetoprotein induced phospho

PP-050 Alpha-fetoprotein induced phosphorylation of AKT via inhibited the activity of PTEN in human hepatoma Bel 7402 cells

✍ Mengsen Li; Sheng Zhou; Mingyue Zhu; Xiaoying Wang; Xinhua Liu; Gang Li 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 80 KB

The role of cell cycle-dependent neuropa

The role of cell cycle-dependent neuropathy target esterase in cell proliferation

✍ Ping-An Chang; Yu-ying Chen; Wen-zhen Qin; Ding-Xin Long; Yi-Jun Wu 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 359 KB

Gefitinib Inhibits the Proliferation of

Gefitinib Inhibits the Proliferation of Pancreatic Cancer Cells via Cell Cycle Arrest

✍ Xiaohua Zhou; Maqing Zheng; Fang Chen; Yunxia Zhu; Wei Yong; Haiyan Lin; Yujie S 📂 Article 📅 2009 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 281 KB 👁 2 views

## Abstract High expression of the epidermal growth factor receptor (EGFR) has been implicated in the development of pancreatic cancer. Gefitinib is an orally active and selective EGFR‐TKI (EGFR‐tyrosine kinase inhibitor) that blocks signal transduction pathways responsible for the proliferation an